A team of researchers has developed a noninvasive diagnostic method that may one day replace the biopsy with a simple blood test. Glioblastomas are aggressive brain tumors that are commonly diagnosed ...

GLASGOW, Scotland--(BUSINESS WIRE)--Dxcover Limited, a clinical-stage diagnostics company pioneering multi-omic spectral analysis (MOSA) for early detection of multiple cancers, today announced it is ...

Neural networks trained with a camouflage detection step show enhanced accuracy and sensitivity in identifying brain tumors from MRI scans, mimicking expert radiologists. Study: Deep learning and ...

Dxcover, a developer of AI-enabled medical diagnostic technology originally spun-out from the University of Strathclyde, has announced availability of its blood-based brain cancer early detection test ...